ClinicalTrials.gov record
Recruiting Phase 4 Interventional

Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones

ClinicalTrials.gov ID: NCT06003348

Public ClinicalTrials.gov record NCT06003348. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 7:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT06003348
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
University of Texas Southwestern Medical Center
Other
Enrollment
25 participants

Conditions and interventions

Interventions

  • OHCit- low dose Dietary Supplement
  • OHCit- standard dose Dietary Supplement
  • Placebo Drug
  • Potassium Citrate Drug

Dietary Supplement · Drug

Eligibility (public fields only)

Age range
21 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 12, 2023
Primary completion
May 30, 2028
Completion
Aug 30, 2028
Last update posted
Apr 5, 2025

2023 – 2028

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
UT Southwestern Medical Center Dallas Texas 75390-8885 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06003348, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 5, 2025 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06003348 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →